Exchange: NYSE Sector: Healthcare Industry: Medical Instruments & Supplies
0.00% $0.660
America/New_York / 31 jan 2023 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 24.91 mill |
EPS: | -0.830 |
P/E: | -0.795 |
Earnings Date: | May 08, 2023 |
SharesOutstanding: | 37.75 mill |
Avg Daily Volume: | 0.954 mill |
RATING 2023-03-30 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.795 | sector: PE 15.43 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.02x |
Company: PE -0.795 | industry: PE 42.42 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.584 - 0.736 ( +/- 11.52%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-13 | Davidson Kempner Capital Management Lp | Buy | 1 404 736 | Common Stock, par value $0.001 per share ("Common Stock") |
2024-01-31 | Davidson Kempner Capital Management Lp | Buy | 0 | Common Stock, par value $0.001 per share ("Common Stock") |
2024-01-31 | Davidson Kempner Capital Management Lp | Buy | 7 259 791 | 9.00% Series A Convertible Participating Preferred Stock |
2023-11-01 | Ferreira Cintia | Buy | 372 484 | Employee Stock Option (Right to Buy) |
2023-11-01 | Ferreira Cintia | Buy | 84 000 | Common Stock |
INSIDER POWER |
---|
18.88 |
Last 67 transactions |
Buy: 15 726 013 | Sell: 14 206 345 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.660 (0.00% ) |
Volume | 0 mill |
Avg. Vol. | 0.954 mill |
% of Avg. Vol | 0 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.